SC
Satyam Chopra
About Satyam Chopra
Data last updated:
Satyam Chopra is an Additional Director at Epazote Pharmaceuticals Private Limited (since 2023). The company operates in Chemicals. Epazote Pharmaceuticals Private Limited reported revenue of ₹1.6 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 03 May 2023 | 2020 | ₹1.6 Lakh (FY 2022) | Active |
Board colleagues of Satyam Chopra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vimal Chopra | 08858619 | Epazote Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyam Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyam Chopra
Satyam Chopra currently holds 1 directorship: Epazote Pharmaceuticals Private Limited (Additional Director, since 03 May 2023, revenue ₹1.6 Lakh (FY 2022)).
Satyam Chopra was first appointed on 03 May 2023 as Additional Director at Epazote Pharmaceuticals Private Limited.
The current boards of Satyam Chopra's companies include Vimal Chopra (Epazote Pharmaceuticals Private Limited).